date:Jul 22, 2022
mbling to find infant formula, the FDA greenlighted the company to restart production at its contentious Sturgis plant in Michigan.
A previous on-site inspection revealed five environmental subsamples were positive for Cronobacter sakazakii at the facility. The FDA noted Abbott Nutrition failed to ensure that all surfaces in contact with infant formula were maintained to protect the product from being contaminated by any source. Product samples analyzed for Cronobacter were found negative.
It